These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 36611887)

  • 1. Kidney Proximal Tubule GLUT2-More than Meets the Eye.
    Ahmad M; Abramovich I; Agranovich B; Nemirovski A; Gottlieb E; Hinden L; Tam J
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of diabesity-induced kidney disease: role of kidney nutrient sensing.
    Hinden L; Kogot-Levin A; Tam J; Leibowitz G
    FEBS J; 2022 Feb; 289(4):901-921. PubMed ID: 33630415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do Endocannabinoids Regulate Glucose Reabsorption in the Kidney?
    Hinden L; Tam J
    Nephron; 2019; 143(1):24-27. PubMed ID: 30636250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental type II diabetes and related models of impaired glucose metabolism differentially regulate glucose transporters at the proximal tubule brush border membrane.
    Chichger H; Cleasby ME; Srai SK; Unwin RJ; Debnam ES; Marks J
    Exp Physiol; 2016 Jun; 101(6):731-42. PubMed ID: 27164183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposite physiological and pathological mTORC1-mediated roles of the CB1 receptor in regulating renal tubular function.
    Hinden L; Ahmad M; Hamad S; Nemirovski A; Szanda G; Glasmacher S; Kogot-Levin A; Abramovitch R; Thorens B; Gertsch J; Leibowitz G; Tam J
    Nat Commun; 2022 Apr; 13(1):1783. PubMed ID: 35379807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SGLT2 Inhibition for the Prevention and Treatment of Diabetic Kidney Disease: A Review.
    Alicic RZ; Johnson EJ; Tuttle KR
    Am J Kidney Dis; 2018 Aug; 72(2):267-277. PubMed ID: 29866460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of Renal GLUT2 by the Cannabinoid-1 Receptor: Implications for the Treatment of Diabetic Nephropathy.
    Hinden L; Udi S; Drori A; Gammal A; Nemirovski A; Hadar R; Baraghithy S; Permyakova A; Geron M; Cohen M; Tsytkin-Kirschenzweig S; Riahi Y; Leibowitz G; Nahmias Y; Priel A; Tam J
    J Am Soc Nephrol; 2018 Feb; 29(2):434-448. PubMed ID: 29030466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium-glucose cotransporter-2 inhibitors for diabetic kidney disease: Targeting Warburg effects in proximal tubular cells.
    Morita M; Kanasaki K
    Diabetes Metab; 2020 Oct; 46(5):353-361. PubMed ID: 32891754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium-glucose cotransporter 2 inhibition suppresses HIF-1α-mediated metabolic switch from lipid oxidation to glycolysis in kidney tubule cells of diabetic mice.
    Cai T; Ke Q; Fang Y; Wen P; Chen H; Yuan Q; Luo J; Zhang Y; Sun Q; Lv Y; Zen K; Jiang L; Zhou Y; Yang J
    Cell Death Dis; 2020 May; 11(5):390. PubMed ID: 32444604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proximal Tubule mTORC1 Is a Central Player in the Pathophysiology of Diabetic Nephropathy and Its Correction by SGLT2 Inhibitors.
    Kogot-Levin A; Hinden L; Riahi Y; Israeli T; Tirosh B; Cerasi E; Mizrachi EB; Tam J; Mosenzon O; Leibowitz G
    Cell Rep; 2020 Jul; 32(4):107954. PubMed ID: 32726619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Basolateral Glucose Increases Sodium-Glucose Cotransporter 2 and Reduces Sirtuin-1 in Renal Tubules through Glucose Transporter-2 Detection.
    Umino H; Hasegawa K; Minakuchi H; Muraoka H; Kawaguchi T; Kanda T; Tokuyama H; Wakino S; Itoh H
    Sci Rep; 2018 May; 8(1):6791. PubMed ID: 29717156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium-Glucose Co-Transporter 2 Inhibitors Correct Metabolic Maladaptation of Proximal Tubular Epithelial Cells in High-Glucose Conditions.
    Shirakawa K; Sano M
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic proximal tubulopathy: Can we mimic the disease for in vitro screening of SGLT inhibitors?
    Faria J; Gerritsen KGF; Nguyen TQ; Mihaila SM; Masereeuw R
    Eur J Pharmacol; 2021 Oct; 908():174378. PubMed ID: 34303664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SGLT2 Inhibitors: Glucotoxicity and Tumorigenesis Downstream the Renal Proximal Tubule?
    Bertinat R; Nualart F; Yáñez AJ
    J Cell Physiol; 2016 Aug; 231(8):1635-7. PubMed ID: 26661279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of SGLT2 inhibition in human kidney proximal tubular cells--renoprotection in diabetic nephropathy?
    Panchapakesan U; Pegg K; Gross S; Komala MG; Mudaliar H; Forbes J; Pollock C; Mather A
    PLoS One; 2013; 8(2):e54442. PubMed ID: 23390498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium glucose cotransporter 2 and the diabetic kidney.
    Komala MG; Panchapakesan U; Pollock C; Mather A
    Curr Opin Nephrol Hypertens; 2013 Jan; 22(1):113-9. PubMed ID: 23042029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tubular hypothesis of nephron filtration and diabetic kidney disease.
    Vallon V; Thomson SC
    Nat Rev Nephrol; 2020 Jun; 16(6):317-336. PubMed ID: 32152499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium/glucose cotransporter 2 inhibitors and prevention of diabetic nephropathy: targeting the renal tubule in diabetes.
    De Nicola L; Gabbai FB; Liberti ME; Sagliocca A; Conte G; Minutolo R
    Am J Kidney Dis; 2014 Jul; 64(1):16-24. PubMed ID: 24673844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory mechanisms of Na(+)/glucose cotransporters in renal proximal tubule cells.
    Lee YJ; Lee YJ; Han HJ
    Kidney Int Suppl; 2007 Aug; (106):S27-35. PubMed ID: 17653207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium glucose cotransporter 2 inhibition in the diabetic kidney: an update.
    Novikov A; Vallon V
    Curr Opin Nephrol Hypertens; 2016 Jan; 25(1):50-8. PubMed ID: 26575393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.